Searchable abstracts of presentations at key conferences in endocrinology
Endocrine Abstracts (2018) 56 GP217 | DOI: 10.1530/endoabs.56.GP217

1Centre Hospitalier Universitaire de Liège, Liège, Belgium; 2Centre Hospitalier Universitaire Erasme, Bruxelles, Belgium; 3Universiteit Gent, Gent, Belgium; 4Université Catholique de Louvain, Louvain, Belgium; 5Centre Hospitalier Saint Joseph, Liège, Belgium; 6UZ Brussel, Bruxelles, Belgium; 7Cliniques Universitaires Saint Luc, Bruxelles, Belgium.


Introduction: CHH is a genetic syndrome that combines reproductive and brain abnormalities. The brain phenotype has been incompletely characterized. We aimed to study neuroradiological and genetic features in this first Belgian series of patients with CHH.

Methods: A series of 56 adult patients (48 males, 8 females) presenting with CHH was investigated for a panel of 16 genes related to hypogonadotropic hypogonadism by next generation sequencing on a MiSeq® Instrument (Illumina) and by using a validated targeted approach with xGen® Lockdown® Probes (IDT). We then reviewed cerebral or hypothalamic-pituitary abnormalities in 32 patients using magnetic resonance imaging (MRI).

Results: Among the 56 patients, we found, up to now, some 26 genetic variants including FGFR1, GnRHR, CDH7, TAC3, WDR11, HS6ST1, PROKR2 and KISSR genes. In this series, five new variants (class3 to 5) were present in the following genes: TAC3 gene (c.238+1 G>A, class 5), FGFR1 gene (c.169C>A, p.Leu57Met, class 3), CDH7 gene (c.7212_7214del,p.Arg2405del, class 3), KISS1R (c.502G>A, p.Val168IIe, class 3) and a deletion of KISSR. A total of 21 patients presented a normal brain MRI, whereas 11 other patients presented structural abnormalities: a Chiari type 1 malformation (CM1) (n=3), an anterior pituitary hypoplasia (n=3), a Rathke’s pouch cyst (n=1), a septo-optic dysplasia (n=2), an hydrocephalus (n=1) and an aracnoidal cyst (n=1). Among the group of abnormal MRI, only one patient with CM1 presented a new pathogenic variant in FGFR1 gene (c.1025T>A; pLeu342*). Among the 21 patients with normal MRI, seven patients were heterozygous for one pathogenic variant.

Discussion: In our cohort, CM1 was found in three of the 32 patients (9.3%) who performed a brain MRI. In the general population, incidence of CM1 is estimated at 0,7%. CM1 and CHH have not been previously reported, although CM1 and cerebellar herniation were seen in GHD or in multiple hormone deficiency patients. We found a new FGFR1 mutation for one of our patients with CM1. Common variants in genes involved in somitogenesis and fetal vascular development may confer a susceptibility for CM1: the contribution of FGFR1 to these defects deserve more investigations.

Conclusion: In this large Belgian series of CHH patients, we describe, for the first time, five new pathogenic variants. Moreover, we suggest a new syndromic association between CHH and CM1. Multicenter studies and systematic brain MRI may be required to extend the phenotype and the genotype of CHH patients.

Volume 56

20th European Congress of Endocrinology

Barcelona, Spain
19 May 2018 - 22 May 2018

European Society of Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.